18F-Fluorodeoxyglucose (FDG) PET/CT is routinely used in oncological imaging. The use of FDG imaging has also expanded beyond oncology to include cardiac viability studies, assessment of neurological diseases including dementia and epilepsy, and evaluation of infection and inflammation. This article briefly summarizes the utility of FDG PET/CT for infection imaging. {read more here}

Three-month 18F-FDG PET/CT imaging helps detect which patients with Hodgkin lymphoma (HL) respond to immune-checkpoint blockade by anti–programmed death 1 antibodies (anti-PD1), according to a study published in the Journal of Nuclear Medicine. {read more here}

By using PET/CT to measure the level of calcium in the coronary arteries during stress tests, clinicians can better predict which patients are at high risk of heart disease, according to a study presented on Monday at the American College of Cardiology (ACC) annual conference in Orlando, FL. {read more here}

Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe obstructive coronary artery disease, according to researchers at the Intermountain Medical Center Heart Institute in Salt Lake City. {read more here}